Company profile
Sonic Incytes
Sonic Incytes has 2 AI-enabled medical devices on the FDA list. The first decision was on April 20, 2023 and the most recent on September 4, 2024 (Velacur). Its most common review panel is Radiology (2 devices).
2AI devices
2023First decision
2024Latest decision
1Specialties